Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.5200
-0.0212 (-3.92%)
Mar 31, 2025, 1:37 PM EDT - Market open
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $153.52 million as of March 31, 2025. Its market cap has decreased by -74.29% in one year.
Market Cap
153.52M
Enterprise Value
-164.80M
1-Year Change
-74.29%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $153.52M, a decrease of -96.28%. That is a compound annual growth rate of -58.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 159.78M | -14.55% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.75B |
| UnitedHealth Group | 474.55B |
| Johnson & Johnson | 395.28B |
| AbbVie | 361.83B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.73B |
| Merck & Co. | 226.41B |
| AstraZeneca | 225.00B |